Correlation Engine 2.0
Clear Search sequence regions

  • lipids (1)
  • liver (2)
  • Ppara (2)
  • serum (1)
  • target drugs (1)
  • target genes (2)
  • wy 14643 (7)
  • Sizes of these terms reflect their relevance to your search.

    Peroxisome proliferator-activated receptor alpha (PPARα) is a molecular target of various fibrate drugs clinically used to lower serum lipids. However, the tissue-specific functions of PPARα remain to be elucidated. This study aimed to explore the tissue-specific functions of PPARα in response to Wy-14643. A hepatocyte-specific Ppara knockout mouse line was used to explore the impact of hepatic PPARα activity on the systemic response to treatment with the potent PPARα agonist Wy-14643. Wy-14643 mainly activated hepatic PPARα and regulated the expression of PPARα target genes in liver. Hepatic Ppara disruption abolished the triglyceride lowering effects of Wy-14643, prevented agonist-induced hypophagia, and ablated target gene response in the liver. These findings indicate that Wy-14643 treatment mainly activates hepatic PPARα, and the hypolipidemic and hypophagic effects of Wy-14643 are dependent on PPARα activation within hepatocytes. This article is protected by copyright. All rights reserved.


    Guolin Li, Chad N Brocker, Cen Xie, Tingting Yan, Audrey Noguchi, Kristopher W Krausz, Rong Xiang, Frank J Gonzalez. Hepatic PPARα mediates the major metabolic effects of Wy-14643. Journal of gastroenterology and hepatology. 2017 Nov 15

    PMID: 29141109

    View Full Text